Discovery by Design at AstraZeneca’s New R&D Facility
This 570,000-square-foot tower will accommodate up to 1,850 employees after it opens in 2026. Teams from AstraZeneca and Alexion Rare Disease will collaborate here to transform the future of healthcare.